In our study, we found a frequency of 4.5% coding TOX3 mutations in primary breast tumours, clustered in exon 3 and in exon 7 (the latter contains the trinucleotide repeat region) (Figure 1B). This evidence concerns the gene TOX3 and breast neoplasm.